Tandlægeselskabet Overgaden I/S — Credit Rating and Financial Key Figures
CVR number: 31763207
Overgaden 4 A, 7080 Børkop
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 037.41 | 2 093.89 | 2 204.62 | 2 095.72 | 2 145.80 |
| Employee benefit expenses | -1 657.84 | -1 773.97 | -1 570.72 | -1 675.07 | -1 630.03 |
| Total depreciation | -44.98 | -44.98 | -44.98 | -44.35 | -41.84 |
| EBIT | 334.60 | 274.94 | 588.93 | 376.30 | 473.93 |
| Other financial income | 2.70 | 2.17 | 3.00 | 1.65 | 2.40 |
| Other financial expenses | - 115.38 | - 100.97 | -72.40 | -72.49 | -58.41 |
| Pre-tax profit | 221.91 | 176.14 | 519.53 | 305.46 | 417.93 |
| Net earnings | 221.91 | 176.14 | 519.53 | 305.46 | 417.93 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Land and waters | 2 647.13 | 2 610.84 | 2 574.55 | 2 538.26 | 2 501.96 |
| Machinery and equipment | 52.30 | 43.62 | 34.93 | 26.88 | 21.33 |
| Tangible assets total | 2 699.43 | 2 654.46 | 2 609.48 | 2 565.13 | 2 523.29 |
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 63.63 | 42.56 | 44.41 | 64.36 | 63.80 |
| Inventories total | 63.63 | 42.56 | 44.41 | 64.36 | 63.80 |
| Current trade debtors | 81.31 | 54.87 | 67.63 | 53.66 | 67.70 |
| Prepayments and accrued income | 1.71 | 8.27 | |||
| Current other receivables | 14.70 | 12.18 | 9.72 | 9.53 | 15.94 |
| Short term receivables total | 97.71 | 67.05 | 77.36 | 71.46 | 83.64 |
| Cash and bank deposits | 1.21 | 0.61 | 4.90 | 0.95 | 5.15 |
| Cash and cash equivalents | 1.21 | 0.61 | 4.90 | 0.95 | 5.15 |
| Balance sheet total (assets) | 2 861.99 | 2 764.67 | 2 736.15 | 2 701.90 | 2 675.88 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Retained earnings | 1 006.78 | 1 152.70 | 1 068.59 | 1 254.48 | 1 236.55 |
| Profit of the financial year | 221.91 | 176.14 | 519.53 | 305.46 | 417.93 |
| Shareholders equity total | 1 228.70 | 1 328.84 | 1 588.12 | 1 559.94 | 1 654.47 |
| Non-current loans from credit institutions | 941.38 | 618.78 | 465.50 | 340.95 | 361.25 |
| Non-current deferred tax liabilities | 191.20 | 204.32 | 210.65 | ||
| Non-current liabilities total | 941.38 | 618.78 | 656.70 | 545.26 | 571.90 |
| Current loans from credit institutions | 468.75 | 479.45 | 332.91 | 435.75 | 220.00 |
| Advances received | 4.69 | 0.85 | 1.20 | 4.31 | 5.69 |
| Current trade creditors | 68.57 | 63.01 | 61.42 | 55.59 | 100.30 |
| Other non-interest bearing current liabilities | 149.90 | 273.74 | 95.80 | 101.05 | 123.52 |
| Current liabilities total | 691.91 | 817.05 | 491.33 | 596.69 | 449.51 |
| Balance sheet total (liabilities) | 2 861.99 | 2 764.67 | 2 736.15 | 2 701.90 | 2 675.88 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.